Opportunity Information: Apply for RFA DD 12 003
Apply for RFA DD 12 003
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Reducing Health Disparities among People with Intellectual Disabilities" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.184 Disabilities Prevention.
- This funding opportunity was created on Jan 24, 2012 and posted on Dec 19, 2011.
- Applicants must submit their applications by Feb 13, 2012 On time submission requires that electronic applications be error free and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 500 PM U.S. Eastern Time. Note HHS/CDC grant submission procedures do not provide a period of time beyond the application due date to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.gov or eRA systems (i.e., error correction window).. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The CDC grant opportunity "Reducing Health Disparities among People with Intellectual Disabilities" (Funding Opportunity Number RFA DD 12 003; CFDA 93.184, Disabilities Prevention) was a discretionary, health-focused cooperative agreement intended to build stronger evidence and practical approaches for closing health gaps experienced by people with intellectual disabilities. The program was structured around two complementary components: one aimed at improving the underlying data and analysis used to understand disparities, and another aimed at testing and learning from real-world practices that could reduce those disparities. In plain terms, the CDC was looking both for better measurement and better solutions.
Component A focused on identifying and addressing unmet health-related needs by strengthening the ability to detect, describe, and explain disparities between people with and without intellectual disabilities. This part of the opportunity emphasized research on valid and reliable data sources and analytic techniques, meaning applicants were expected to examine how intellectual disability is identified (or missed) in existing datasets, how health outcomes and risk factors are measured, and what statistical or methodological approaches best capture the drivers of disparity. The central goal was to improve understanding of risk factors associated with poorer health indicators in this population, which could include medical risk factors, social determinants of health, access-to-care barriers, or system-level factors that contribute to unequal outcomes. Ultimately, Component A was about strengthening the evidence base so public health agencies and partners can make decisions using accurate, defensible information rather than incomplete or inconsistent data.
Component B shifted from measurement to action by supporting evaluation of promising practices that could reduce health disparities for people with intellectual disabilities, specifically in selected key health indicators. While the summary text does not list the exact indicators, the intent was to focus on measurable outcomes where disparities are known or suspected to be significant and where interventions can realistically improve results. The emphasis on "promising practices" suggests the CDC was interested in approaches that already show potential in communities, clinical settings, or service systems, but still need rigorous evaluation to determine whether they work, for whom, and under what conditions. The evaluation focus also implies attention to implementation details, feasibility, and potential for replication or scaling if results are positive.
Administratively, this opportunity was offered as a cooperative agreement, which typically means substantial federal involvement beyond a standard grant, often through technical assistance, collaboration on evaluation design, data standards, dissemination expectations, or alignment with CDC priorities. The CDC anticipated making two awards, with an award ceiling of $250,000 and no cost sharing or matching requirement. Eligibility was unrestricted (open to any type of entity), subject to any additional clarifications in the full announcement. The application deadline was February 13, 2012, with strict electronic submission requirements: applications had to be error-free and validated through Grants.gov and eRA Commons by 5:00 PM U.S. Eastern Time, and there was no post-deadline error-correction window.
For applicants needing help accessing the announcement or navigating submission issues, the listed point of contact was the CDC Procurement and Grants Office, Technical Information and Management Section (TIMS), reachable by phone at 770-488-2700 for general submission inquiries.
Frequently Asked Questions (FAQs)
What is the name of this CDC funding opportunity?
The opportunity is titled "Reducing Health Disparities among People with Intellectual Disabilities".
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is RFA DD 12 003.
What CFDA program is associated with this opportunity?
The opportunity is associated with CFDA 93.184, identified as Disabilities Prevention.
What type of funding mechanism was used?
This was offered as a cooperative agreement, which generally indicates substantial federal involvement beyond what is typical for a standard grant.
What was the overall purpose of the program?
The program was intended to build stronger evidence and practical approaches for closing health gaps experienced by people with intellectual disabilities. It was designed to support both better measurement of disparities and better solutions to reduce them.
How was the program structured?
The program included two complementary components:
- Component A: Improve data and analysis to better detect, describe, and explain health disparities between people with and without intellectual disabilities.
- Component B: Evaluate promising practices that could reduce health disparities for people with intellectual disabilities in selected key health indicators.
What was Component A focused on?
Component A focused on identifying and addressing unmet health-related needs by strengthening the ability to detect, describe, and explain disparities. This emphasized research on valid and reliable data sources and analytic techniques.
What kinds of issues was Component A expected to examine?
Based on the description, Component A activities could include examining:
- How intellectual disability is identified (or missed) in existing datasets
- How health outcomes and risk factors are measured
- Which statistical or methodological approaches best capture the drivers of disparity
What was the main goal of Component A?
The central goal was to improve understanding of risk factors associated with poorer health indicators among people with intellectual disabilities, strengthening the evidence base so decisions can be made using accurate and defensible information.
What types of risk factors were relevant under Component A?
The summary indicates risk factors could include medical risk factors, social determinants of health, access-to-care barriers, and system-level factors that contribute to unequal outcomes.
What was Component B focused on?
Component B shifted from measurement to action by supporting the evaluation of promising practices that could reduce health disparities for people with intellectual disabilities in selected key health indicators.
Does the provided summary list the key health indicators for Component B?
No. The summary notes that the opportunity targeted selected key health indicators, but it does not list the exact indicators.
What does "promising practices" mean in the context of Component B?
In this description, "promising practices" refers to approaches that already show potential in real-world settings (such as communities, clinical settings, or service systems) but still need rigorous evaluation to determine whether they work, for whom, and under what conditions.
What kinds of evaluation considerations were implied for Component B?
The evaluation emphasis implies attention to implementation details, feasibility, and the potential for replication or scaling if results are positive.
How many awards did CDC anticipate making?
CDC anticipated making two awards.
What was the award ceiling?
The award ceiling was $250,000.
Was cost sharing or matching required?
No. The opportunity stated there was no cost sharing or matching requirement.
Who was eligible to apply?
Eligibility was described as unrestricted (open to any type of entity), subject to any additional clarifications that may have been included in the full announcement.
What was the application deadline?
The application deadline was February 13, 2012.
How did applications need to be submitted?
Applications were required to be submitted electronically, and they needed to be error-free and validated through Grants.gov and eRA Commons.
What was the submission cutoff time?
The cutoff time was 5:00 PM U.S. Eastern Time on the deadline date.
Was there a post-deadline window to correct submission errors?
No. The opportunity specified that there was no post-deadline error-correction window.
What does the cooperative agreement structure imply for awardees?
As described, a cooperative agreement typically involves substantial federal involvement, which may include technical assistance, collaboration on evaluation design, data standards, dissemination expectations, or alignment with CDC priorities.
Who was listed as the point of contact for accessing the announcement or submission help?
The listed point of contact was the CDC Procurement and Grants Office, Technical Information and Management Section (TIMS).
What phone number was provided for general submission inquiries?
The phone number provided was 770-488-2700.
Browse more opportunities from the same category: Health
Next opportunity: Cyber Physical Systems
Previous opportunity: FAA Aviation Research and Development Grants
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DD 12 003
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DD 12 003) also looked into and applied for these:
| Funding Opportunity |
|---|
| Service Area Competition Additional Areas (Boydton, VA) Apply for HRSA 12 168 Funding Number: HRSA 12 168 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| State Implementation Grants for Systems of Services for Children and Youth with Special Health Care Needs (CYSHCN) Apply for HRSA 12 049 Funding Number: HRSA 12 049 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| New England Region AIDS Education and Training Center Program(s) (AETC) Apply for HRSA 12 124 Funding Number: HRSA 12 124 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Network and Infrastructure Support for Development of Interdisciplinary Aging Research (R24) Apply for PA 12 064 Funding Number: PA 12 064 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Human Heredity and Health in Africa (H3Africa) H3Africa Biorepository Grants (UH2/UH3) Apply for RFA RM 12 003 Funding Number: RFA RM 12 003 Agency: National Institutes of Health Category: Health Funding Amount: $115,000 |
| HIV Innovations for Improved Patient Outcomes for Priority Populations Apply for 674 12 000003 Funding Number: 674 12 000003 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $15,000,000 |
| Public Health Traineeships Apply for HRSA 12 005 Funding Number: HRSA 12 005 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Faculty Development in General, Pediatric, and Public Health Dentistry and Dental Hygiene Apply for HRSA 12 109 Funding Number: HRSA 12 109 Agency: Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| Training Programs for Critical HIV Research Infrastructure for Low and Middle Income Country Institutions (G11) Apply for PAR 12 069 Funding Number: PAR 12 069 Agency: National Institutes of Health Category: Health Funding Amount: $92,000 |
| Limited Competition Planning Grant for Fogarty HIV Research Training Program for Low and Middle Income Country Institutions (D71) Apply for PAR 12 070 Funding Number: PAR 12 070 Agency: National Institutes of Health Category: Health Funding Amount: $28,000 |
| Grants to States to Support Oral Health Workforce Activities Apply for HRSA 12 028 Funding Number: HRSA 12 028 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Domestic Violence Prevention Enhancement and Leadership Through Alliance (DELTA) III Program Apply for CDC RFA CE09 9010301SUPP12 Funding Number: CDC RFA CE09 9010301SUPP12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $420,000 |
| SAVING LIVES AT BIRTH A GRAND CHALLENGE Apply for DRAFT RFA OAA 12 000006 Funding Number: DRAFT RFA OAA 12 000006 Agency: Agency for International Development Category: Health Funding Amount: $13,000,000 |
| Evaluation of Dengue Epidemiology, Outcomes, and Prevention in Sentinel Surveillance and Research Sites in Puerto Rico Apply for RFA CK 12 001 Funding Number: RFA CK 12 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Operations Research (Implementation Science) for Strengthening Program Implementation through the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for RFA GH 12 008 Funding Number: RFA GH 12 008 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Provision of Comprehensive HIV/AIDS Care, Treatment and Prevention Services in indigenous Health Facilities in the Republic of Uganda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1209 Funding Number: CDC RFA GH12 1209 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| A Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Apply for RFA DD 12 002 Funding Number: RFA DD 12 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Collaborative R34s for Pilot Studies of Innovative Treatments in Mental Disorders (Collaborative R34) Apply for PAR 12 071 Funding Number: PAR 12 071 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Clinical Trials in Organ Transplantation in Children (U01) Apply for RFA AI 12 005 Funding Number: RFA AI 12 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Identifying Reasons for Racial/Ethnic Disparities with Completing the HPV Vaccine Series among Adolescent Females Apply for RFA IP 12 004 Funding Number: RFA IP 12 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DD 12 003", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.